Proteasome inhibition by bortezomib increases IL-8 expression in androgen-independent prostate cancer cells: the role of IKKα.
Proteasome inhibition by bortezomib increases IL-8 expression in androgen-independent prostate cancer cells: the role of IKKα.
复制标题
DOI:
10.4049/jimmunol.1300895
复制
发表时间:
2013-09-01
期刊:
影响因子:
--
通讯作者:
Vancurova I
中科院分区:
文献类型:
--
作者:
Manna S;Singha B;Phyo SA;Gatla HR;Chang TP;Sanacora S;Ramaswami S;Vancurova I
Expression of the pro-inflammatory and pro-angiogenic chemokine interleukin-8 (IL-8), which is regulated at the transcriptional level by NFκB, is constitutively increased in the androgen independent metastatic prostate cancer and correlates with poor prognosis. Inhibition of NFκB-dependent transcription was used as an anti-cancer strategy for the development of the first clinically approved 26S proteasome inhibitor, bortezomib (BZ). Even though BZ has shown remarkable anti-tumor activity in hematological malignancies, it has been less effective in prostate cancer and other solid tumors; however, the mechanisms have not been fully understood. Here we report that the proteasome inhibition by BZ unexpectedly increases the IL-8 expression in androgen independent prostate cancer PC3 and DU145 cells, while expression of other NFκB-regulated genes is inhibited or unchanged. The BZ-increased IL-8 expression is associated with increased in vitro p65 NFκB DNA binding activity and p65 recruitment to the endogenous IL-8 promoter. In addition, proteasome inhibition induces a nuclear accumulation of IKKα and inhibition of IKKα enzymatic activity significantly attenuates the BZ-induced p65 recruitment to IL-8 promoter and IL-8 expression, demonstrating that the induced IL-8 expression is mediated, at least partly, by IKKα. Together, these data provide the first evidence for the gene specific increase of IL-8 expression by the proteasome inhibition in prostate cancer cells and suggest that targeting both IKKα and the proteasome may increase the BZ effectiveness in androgen independent prostate cancer treatment.
登录
查看更多内容
影响因子:
4.8
作者:
Dolcet, Xavier;Llobet, David;Matias-Guiu, Xavier
通讯作者:
Matias-Guiu, Xavier
影响因子:
5.8
作者:
Cullen, Sarah J.;Ponnappan, Subramaniam;Ponnappan, Usha
通讯作者:
Ponnappan, Usha
影响因子:
12.4
作者:
Demarchi, F;Bertoli, C;Schneider, C
通讯作者:
Schneider, C
影响因子:
5.3
作者:
Hoberg, JE;Popko, AE;Mayo, MW
通讯作者:
Mayo, MW
影响因子:
8
作者:
Broemer, M;Krappmann, D;Scheidereit, C
通讯作者:
Scheidereit, C